From the Helm: CSL’s David Lamont on the biotech giant’s bright future

Jessica Amir
February 20, 2020

In the latest instalment of Bell Direct’s From the Helm series, Jess has a chat with CSL’s CFO David Lamont.

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Morning Bell 5 August

Geoff Beeston
August 5, 2020

Morning Bell 4 August

Jessica Amir
August 4, 2020

Morning Bell 3 August

Jessica Amir
August 3, 2020

Monthly Wrap July 2020

Jessica Amir
July 31, 2020

Morning Bell 31 July

Jessica Amir
July 31, 2020

How to: Get a stock quote

Bell Direct
July 30, 2020

How to: Review your portfolio

Bell Direct
July 30, 2020

How to: Set a trading alert

Bell Direct
July 30, 2020

How to: Place, amend or cancel a trade

Bell Direct
July 30, 2020

How to: Open a trading account

Bell Direct
July 30, 2020